July 23rd, 2013
Funding for Landmark Framingham Heart Study Slashed by $4 Million
Larry Husten, PHD
One of the most important studies in the history of medicine will be sharply curtailed as a result of the federal budget cuts. The landmark Framingham Heart Study (FHS) has been told by the National Heart, Lung and Blood Institute (NHLBI) that it will lose $4 million of its funding. The cut represents 40% of its NHLBI […]
September 10th, 2012
Selections from Richard Lehman’s Literature Review: September 10th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the safety risks of drugs that have gone through the FDA’s expedited approval program, a Framingham Heart Study paper on aortic stiffness in the elderly, and using CMR to detect previously undetected MI in older adults.
August 23rd, 2011
William Kannel, Former Framingham Heart Study Director, Dead at 87
Larry Husten, PHD
William Kannel, the cardiovascular epidemiologist who helped find most of the major risk factors for cardiovascular disease during his lifelong association with the Framingham Heart Study (FHS), died on Saturday at the age of 87. Indeed, Kannel coined the term “risk factor” in a 1961 article in Annals of Internal Medicine. Kannel “made the courageous decision […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy